Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders

NCT07329257 is registered in ClinicalTrials.gov with University of Missouri-Columbia as lead sponsor.

NCT NCT07329257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07329257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders
Lead sponsor
University of Missouri-Columbia
Phase
Observational
Overall status
Recruiting
Start date
December 4, 2025
Completion date
December 31, 2028
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism in children, baker gordon syndrome, developmental delay (disorder), epilepsy, genetic mutations, rare neurodevelopmental conditions, rare neurogenetic conditions, seizure, syt-1 disorder